Should First-line Empiric Treatment Strategies for Neonates Cover Coagulase-negative Staphylococcal Infections in Kenya?
Anna C. Seale(Farr Institute), James A. Berkley(University of Oxford), Susan C. Morpeth, Christina W. Obiero(Imperial College London), Neema Mturi(Kenya Medical Research Institute), Shebe Mohammed(Kenya Medical Research Institute), Greg Fegan(Kenya Medical Research Institute), Moses M. Ngari(Kenya Medical Research Institute), Johnstone Thitiri(Kenya Medical Research Institute), Hellen C. Barsosio(Liverpool School of Tropical Medicine), Kelsey Jones(Imperial College London)
Cited by 9
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
|The Lancet|2011|999
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
|Clinical Infectious Diseases|2017|453
Count every newborn; a measurement improvement roadmap for coverage data
|BMC Pregnancy and Childbirth|2015|366
Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses
|Clinical Infectious Diseases|2017|210